Rolitetracycline
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Other names | (2Z,4S,4aS,5aS,6S,12aS)-4-Dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.938 |
| Chemical and physical data | |
| Formula | C27H33N3O8 |
| Molar mass | 527.574 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
Rolitetracycline is a tetracycline antibiotic.[1] Tetracycline is N-Mannich base prodrug that is prepared from tetracycline by condensation with pyrrolidine and formaldehyde to produce rolitetracycline.
References
- ↑ "Rolitetracycline". PubChem. National Library of Medicine. Retrieved 8 June 2020.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

